GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of 76.79 billion. The enterprise value is 92.39 billion.
Market Cap | 76.79B |
Enterprise Value | 92.39B |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
Earnings Date | Apr 28, 2025 |
Ex-Dividend Date | Feb 20, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.75% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.94B |
Valuation Ratios
The trailing PE ratio is 23.82.
PE Ratio | 23.82 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.39, with an EV/FCF ratio of 14.32.
EV / Earnings | 28.66 |
EV / Sales | 2.28 |
EV / EBITDA | 8.39 |
EV / EBIT | 11.57 |
EV / FCF | 14.32 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.30.
Current Ratio | 0.78 |
Quick Ratio | 0.50 |
Debt / Equity | 1.30 |
Debt / EBITDA | 1.99 |
Debt / FCF | 3.30 |
Interest Coverage | 10.06 |
Financial Efficiency
Return on equity (ROE) is 22.80% and return on invested capital (ROIC) is 12.70%.
Return on Equity (ROE) | 22.80% |
Return on Assets (ROA) | 6.52% |
Return on Invested Capital (ROIC) | 12.70% |
Return on Capital Employed (ROCE) | 16.37% |
Revenue Per Employee | 572,359 |
Profits Per Employee | 46,973 |
Employee Count | 68,629 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.58 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.09% in the last 52 weeks. The beta is 0.29, so GSK plc's price volatility has been lower than the market average.
Beta (5Y) | 0.29 |
52-Week Price Change | -5.09% |
50-Day Moving Average | 18.46 |
200-Day Moving Average | 18.93 |
Relative Strength Index (RSI) | 59.81 |
Average Volume (20 Days) | 2,093 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of 39.28 billion and earned 3.22 billion in profits. Earnings per share was 0.78.
Revenue | 39.28B |
Gross Profit | 28.21B |
Operating Income | 7.74B |
Pretax Income | 4.35B |
Net Income | 3.22B |
EBITDA | 10.41B |
EBIT | 7.74B |
Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 5.42 billion in cash and 21.27 billion in debt, giving a net cash position of -15.85 billion.
Cash & Cash Equivalents | 5.42B |
Total Debt | 21.27B |
Net Cash | -15.85B |
Net Cash Per Share | n/a |
Equity (Book Value) | 16.38B |
Book Value Per Share | 4.19 |
Working Capital | -5.88B |
Cash Flow
In the last 12 months, operating cash flow was 8.21 billion and capital expenditures -1.75 billion, giving a free cash flow of 6.45 billion.
Operating Cash Flow | 8.21B |
Capital Expenditures | -1.75B |
Free Cash Flow | 6.45B |
FCF Per Share | n/a |
Margins
Gross margin is 71.81%, with operating and profit margins of 19.71% and 8.21%.
Gross Margin | 71.81% |
Operating Margin | 19.71% |
Pretax Margin | 11.08% |
Profit Margin | 8.21% |
EBITDA Margin | 26.49% |
EBIT Margin | 19.71% |
FCF Margin | 16.43% |
Dividends & Yields
This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 3.81%.
Dividend Per Share | 0.77 |
Dividend Yield | 3.81% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 94.91% |
Buyback Yield | -0.75% |
Shareholder Yield | 3.05% |
Earnings Yield | 4.20% |
FCF Yield | 8.40% |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
Last Split Date | Jul 19, 2022 |
Split Type | Reverse |
Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.81. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.81 |
Piotroski F-Score | n/a |